Dr. Ryan Rader
- Gender: Male
- Sole propriator: No
- NPI: 1407389455
Dr. Ryan Rader MD
Hematology and Oncology Specialist
He is located at 4881 Northeast Goodview Circle in Lees Summit, MO 64064. Can help patients with the following: Cancer, Hodgkin's Disease, Multiple Myeloma, Non-Hodgkin's Lymphoma (NHL), Polycythemia, Pulmonary Embolism (PE). His National Provider Identifier (NPI) number is 1407389455. Appointment can be made via the phone number (913) 588-1227.
Conditions treated
Dr. Ryan Rader, being an hematology and oncology specialist, treats the following conditions. Please be advised that this list may not be complete. For the full list of conditions treated, consult directly with Dr. Ryan Rader.
- Anemia
- Beta Thalassemia
- Bone Cancer
- Cancer
- Deep Vein Thrombosis (DVT)
- Hemophilia
- Hodgkin's Disease
- Idiopathic Thrombocytopenic Purpura (ITP)
- Leukemia
- Multiple Myeloma
- Neutropenia
- Non-Hodgkin's Lymphoma (NHL)
- Pernicious Anemia
- Polycythemia
- Pulmonary Embolism (PE)
- Sickle Cell Anemia
- Thalassemia
- Thrombocytopenia
ACA Marketplace (Obamacare/HealthCare.gov) plan networks
Insurers selling ACA Marketplace (HealthCare.gov) plans list Dr. Ryan Rader as in-network for the following 2026 plans.
Health plans
Anthem Blue Cross and Blue Shield
Network data as of Mar 26, 2026, as reported by the insurer.
Show all 10 plans from Anthem Blue Cross and Blue Shield
| Plan | Plan type | Network tier | New patients |
|---|---|---|---|
| Anthem Bronze Pathway 10150 ($0 Virtual PCP + $0 Select Drugs + Incentives) | EPO · Bronze | Participating | Accepting new patients |
| Anthem Bronze Pathway 6900 ($0 Virtual PCP + $0 Select Drugs + Incentives) | EPO · Expanded Bronze | Participating | Accepting new patients |
| Anthem Bronze Pathway 7500 Standard ($0 Virtual PCP + $0 Select Drugs + Incentives) | EPO · Expanded Bronze | Participating | Accepting new patients |
| Anthem Catastrophic Pathway (+ Incentives) | EPO · Catastrophic | Participating | Accepting new patients |
| Anthem Gold Pathway 2000 Standard ($0 Virtual PCP + $0 Select Drugs + Incentives) | EPO · Gold | Participating | Accepting new patients |
| Anthem Heart Healthy Bronze Pathway 4900 ($0 Virtual PCP + $0 Select Drugs + Incentives) | EPO · Expanded Bronze | Participating | Accepting new patients |
| Anthem Heart Healthy Silver Pathway 3100 ($0 Virtual PCP + $0 Select Drugs + Incentives) | EPO · Silver | Participating | Accepting new patients |
| Anthem Silver Pathway 5350 ($0 Virtual PCP + $0 Select Drugs + Incentives) | EPO · Silver | Participating | Accepting new patients |
| Anthem Silver Pathway 6000 Standard ($0 Virtual PCP + $0 Select Drugs + Incentives) | EPO · Silver | Participating | Accepting new patients |
| Anthem Silver Pathway 7200 ($0 Virtual PCP + $0 Select Drugs + Incentives) | EPO · Silver | Participating | Accepting new patients |
Blue Cross and Blue Shield of Kansas City
Network data as of Sep 8, 2026, as reported by the insurer.
| Plan | Plan type | Network tier | New patients |
|---|---|---|---|
| Blue KC Community Silver Preferred-Care Blue EPO | EPO · Silver | Preferred | Accepting new patients |
| Blue KC First Bronze Preferred-Care Blue EPO | EPO · Expanded Bronze | Preferred | Accepting new patients |
| Blue KC Standard Bronze Preferred-Care Blue EPO | EPO · Expanded Bronze | Preferred | Accepting new patients |
| Blue KC Standard Gold Preferred-Care Blue EPO | EPO · Gold | Preferred | Accepting new patients |
| Blue KC Standard Silver Preferred-Care Blue EPO | EPO · Silver | Preferred | Accepting new patients |
Oscar Insurance Company
Network data as of Sep 15, 2026, as reported by the insurer.
Show all 11 plans from Oscar Insurance Company
| Plan | Plan type | Network tier | New patients |
|---|---|---|---|
| Bronze Classic 4700 | EPO · Expanded Bronze | Preferred | Accepting new patients |
| Bronze Classic Standard | EPO · Expanded Bronze | Preferred | Accepting new patients |
| Bronze Elite + PCP Saver Plus | EPO · Expanded Bronze | Preferred | Accepting new patients |
| Bronze Simple Diabetes | EPO · Expanded Bronze | Preferred | Accepting new patients |
| Gold Classic Standard | EPO · Gold | Preferred | Accepting new patients |
| Gold Simple | EPO · Gold | Preferred | Accepting new patients |
| Silver Classic Standard | EPO · Silver | Preferred | Accepting new patients |
| Silver Elite Saver Plus | EPO · Silver | Preferred | Accepting new patients |
| Silver Simple Diabetes | EPO · Silver | Preferred | Accepting new patients |
| Silver Simple PCP Saver | EPO · Silver | Preferred | Accepting new patients |
| Silver Simple Women's Health with Menopause Benefits | EPO · Silver | Preferred | Accepting new patients |
This covers ACA Marketplace plans only, as reported by each insurer. It does not include employer, Medicare Advantage, or state-run exchange plans, and a plan missing from this list does not mean Dr. Ryan Rader is out of network. Insurer directories can be out of date, so always confirm with the insurer and the office before your visit.
Medicare Enrollment
Dr. Ryan Rader is enrolled to bill Medicare as a Practitioner - Medical Oncology (also registered under: Practitioner - Hematology) .
Bills through: University Of Kansas Hospital Authority
Based on Medicare's public enrollment records as of Sep 29, 2026. This reflects Medicare fee-for-service enrollment only and says nothing about other insurance, quality, outcomes, or board certification.
Payments received from industry
- $6,645.94 in general payments (consulting fees, meals, travel, gifts, etc.) across 42 payments
Professional & research payments
| Category | Amount | Payments |
|---|---|---|
| Consulting fees | $4,927.50 | 4 |
Meals, travel & gifts
| Category | Amount | Payments |
|---|---|---|
| Food and beverage | $1,706.56 | 37 |
Other payments
| Category | Amount | Payments |
|---|---|---|
| Education | $11.88 | 1 |
Companies that paid this doctor
| Company | Amount | Payments |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,908.36 | 5 |
| Gilead Sciences, Inc. | $1,180.02 | 2 |
| Foundation Medicine, Inc. | $445.55 | 6 |
| Stemline Therapeutics Inc. | $234.93 | 3 |
| Tactile Systems Technology Inc | $124.00 | 1 |
| Merck Sharp & Dohme LLC | $119.36 | 3 |
| Incyte Corporation | $113.35 | 1 |
| Myriad Genetic Laboratories, Inc. | $96.32 | 1 |
| Celgene Corporation | $77.83 | 4 |
| E.R. Squibb & Sons, L.L.C. | $77.39 | 1 |
Based on CMS Open Payments data collected as of Sep 10, 2026. This reflects only payments CMS classifies as reportable and published under the Physician Payments Sunshine Act - it is not a complete picture of every financial relationship, and it is not a comment on the quality of care Dr. Ryan Rader provides.
Additional Specialities
- Resident
Looking for more Hematology and Oncology Specialists?
Here are hematology and oncology specialists in Missouri you may want to explore.
- Gender: Female
- Address: 2316 East Meyer Boulevard Kansas City, 64132, MO
- Gender: Male
- Address: Div Ped Hematology And Onc 1 Childrens Place Saint Louis, 63110, MO
- Gender: Male
- Address: One Hospital Drive Columbia, 65212, MO
- Gender: Male
- Address: 1350 US Highway 61 Festus, 63028, MO
- Gender: Female
- Address: 15945 Clayton Road Suite 120 Ballwin, 63011, MO
- Gender: Male
- Address: 1241 West Stadium Boulevard Jefferson City, 65109, MO
- Gender: Male
- Address: Ste 302 6400 Clayton Road St Louis, 63117, MO
- Gender: Female
- Address: 3315 Mcintosh Circle Joplin, 64804, MO
- Gender: Female
- Address: 400 Medical Plaza Suite 100 Lake St Louis, 63367, MO
- Gender: Female
- Address: Suite 1000 2115 South Fremont Avenue Springfield, 65804, MO
Questions & Answers
Where can you meet with Dr. Ryan Rader?
Dr. Ryan Rader's office is located at 4881 Northeast Goodview Circle in Lees Summit, MO 64064.
Does Dr. Ryan Rader accept insurance?
Dr. Ryan Rader is listed in-network for 26 ACA Marketplace (Obamacare/HealthCare.gov) plans from Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Kansas City, Oscar Insurance Company. See the Marketplace plans section for details.
What conditions does Dr. Ryan Rader treat?
Dr. Ryan Rader provides treatment for Cancer, Hodgkin's Disease, Multiple Myeloma, Non-Hodgkin's Lymphoma (NHL), Polycythemia, Pulmonary Embolism (PE). For the full list see this list.